National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Jakavi® is indicated for the treatment of adult patients with polycythaemia vera who are resistant to or intolerant of hydroxyurea.

Rapid Review

Commenced Completed Outcome
15/04/2015 28/05/2015 Full Pharmacoeconomic Evaluation Recommended

Pharmacoeconomic Evaluation

Commenced Completed Outcome
13/04/2016  16/08/2016 Reimbursement Not Recommended

Summary